Toshiba has successfully developed the world’s smallest rotating gantry in the field of Heavy Ion therapy by using superconducting technologies. Through the 360° rotation, you can now target tumors from any desired direction. Learn how this technology can advance your Cancer Center, revolutionizing the treatment you can offer your patients.
Cancer causes the largest number of illness-related deaths per year, compared to any other disease. That's why our team at Toshiba has channeled our efforts into building a patented and trusted heavy ion therapy system in hopes of changing the future of cancer care. Using new Heavy Ion technology, we have created a system that can concentrate medicine doses on cancer cells with a high relative biological effectiveness (RBE).
Our patented and trusted Heavy Ion therapy systems includes proven and exclusive technologies that the team at Toshiba developed in collaboration with the team at the National Institute of Radiological Sciences in Japan (NIRS/QST). Each system provides both compact rotating gantry treatment as well as fixed beam room treatments that have customizable layouts according to a customer's wants and needs.
With our proven and exclusive Heavy Ion technologies, the team at Toshiba has been able to successfully downsize rotating gantry structures to be comparable with proton gantries by applying cutting-edge superconducting magnet and scanning system technology. This has effectively reduced the patient's physical and mental burden and shortened overall positioned time.
Toshiba has successfully downsized our rotating gantry structure to be comparable with proton gantries by applying cutting-edge superconducting magnet and scanning system technologies. A rotating gantry treatment room provides a customer with several benefits for advanced treatments:
Heavy ion therapy provides excellent dose distribution for tumor volume compared to photon and proton therapy, because of the physical properties of the charged particles; meaning the sharp Bragg peak and small scattering angle, which reduce side effects for normal tissue and adjacent organs. The relative effectiveness of photon and proton therapy compared to Toshiba's Heavy Ion therapy is minimal. Further, the linear energy transfer (LET) for heavy ion beams is known to exhibit large relative biological effectiveness (RBE) at the tumor position. These properties realize precision radiotherapy that is unique and unparalleled to the conventional radiotherapy.
By creating one of the worlds most advanced Heavy Ion therapy systems with proven and cutting-edge technology, Toshiba is stepping forward internationally to provide the best care for each and every patient.
Toshiba has developed the most advanced heavy ion therapy system, with cutting-edge technologies, in collaboration with National Institute of Radiological Sciences in Japan. Toshiba is now stepping forward internationally with our advanced technologies to realize the best care for each and every patient.
